Chronic Myoclonia of Subcortical Origin With Antiglutamate Receptor Antibodies

Abstract

We report a 10-year-old girl with chronic nonprogressive continuous myoclonia with mild muscle weakness and dissociated sensory impairment of the ipsilateral side of myoclonic jerks. Irregular myoclonic jerks continuously appeared in the right upper limb. The jerk-locked back averaging of electroencephalographic activity failed to show any activity preceded by the muscle contraction. Magnetic resonance imaging of the brain and cervical spine revealed no abnormal findings. Single photon emission computed tomography showed an increased blood perfusion in the left thalamus. ¹⁸F-deoxyglucose-positron emission tomography (PET) also showed a slight high density in the posterior region of the left thalamus. Antiglutamate receptor ε2 and δ2 antibodies were detected in the serum and cerebrospinal fluid. The patient's symptoms have now been stable with clonazepam treatment for 2 years. The left thalamus was suspected to have been the region at least partly responsible for the patient's symptoms.

Keywords

myoclonus epilepsia partialis continua antiglutamate receptor antibody jerk-locked back averaging thalamus

Get full access to this article

View all access options for this article.

References

Shibasaki H. Overview and classification of myoclonus. Clin Neurosci. 1995;3:189-192.

Hallett M. , Chadwick D. , Marsden CD Ballistic movement overflow myoclonus a form of essential myoclonus. Brain. 1977; 100:299-312.

Lundemo G. , Persson HE Hereditary essential myoclonus. Acta Neurol Scand. 1985;72:176-179.

Rogers SW , Andrews PI , Gahring LC , et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis . Science. 1994;265:648-651.

Takahashi Y. , Mori H. , Mishina M. , et al. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology. 2003;61:891-896.

Bien CG , Widman G. , Urbach H. , et al. The natural history of Rasmussen's encephalitis. Brain. 2002;125:1751-1759.

Lehericy S. , Grand S. , Pollak P. , et al. Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology. 2001;57:1055-1066.

Gatto EM , Zurru MC , Rugilo C. , et al. Focal myoclonus associated with posterior thalamic hematoma . Mov Disord. 1998; 13:182-184.

Kupsch A. , Trottenberg T. , Meissner W. , et al. Neurostimulation of the ventral intermediate thalamic nucleus alleviates hereditary essential myoclonus. J Neurol Neurosurg Psychiatry. 1999; 67:415-416.

10.

Asenbaum S. , Baumgartner C. Nuclear medicine in the preoperative evaluation of epilepsy. Nucl Med Commun. 2001;22:835-840.

11.

Jones EG , Tighilet B. , Tran BV , et al. Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus. J Comp Neurol. 1998;397:371-393.

12.

Takahashi Y. , Mori H. , Mishina M. , et al. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua. Epilepsia. 2005;46(suppl 5):152-158.

13.

Araki K. , Meguro H. , Kushiya E. , et al. Selective expression of the glutamate receptor channel delta 2 subunit in cerebellar Purkinje cells. Biochem Biophys Res Commun. 1993;197:1267-1276.

14.

Mori H. , Mishina M. Roles of diverse glutamate receptors in brain functions elucidated by subunit-specific and region-specific gene targeting. Life Sci. 2003;74:329-336.

15.

Sugiyama N. , Hamano S. , Mochizuki M. , et al. A case of chronic cerebellitis with anti-glutamate receptor delta 2 antibody. No To Hattatsu. 2004;36:60-63.

16.

Takahashi Y. , Nishimura S. , Sakaguchi N. , et al. Anti-GluR delta2 antibodies in opsoclonus-myoclonus syndrome. Neuroimmunology Shinkeimen-ekigaku. 2003;11:78.

17.

Ito H. , Mori K. , Toda Y. , et al. A case of acute encephalitis with refractory, repetitive partial seizures, presenting autoantibody to glutamate receptor Gluepsilon2. Brain Dev. 2005;27:531-534.

18.

Mochizuki Y. , Mizutani T. , Isozaki E. , et al. Acute limbic encephalitis: a new entity? Neurosci Lett. 2006;394:5-8.